SinisaDovatMD
Pediatric Hematology & Oncology • Hershey, PAProfessor, Pediatrics, Pennsylvania State University College of Medicine
Dr. Dovat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
Hershey, PA 17033Phone+1 800-243-1455Fax+1 608-263-0440
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 1996 - 1999
Penn State Milton S Hershey Medical CenterResidency, Pediatrics, 1993 - 1996
University of Novi Sad Faculty of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 1996 - Present
PA State Medical License 1994 - 2024
WI State Medical License 2004 - 2021- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 12 citationsSynergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia.Siyu Gu, Yue Hou, Katarina Dovat, Sinisa Dovat, Chunhua Song
Experimental Hematology & Oncology. 2023-02-27 - 31 citationsIKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemiaChunhua Song, Zheng Ge, Yali Ding, Bi-Hua Tan, Dhimant Desai
Blood. 2020-09-24 - 49 citationsIkaros and Tumor Suppression in Acute Lymphoblastic LeukemiaKimberly J. Payne, Sinisa Dovat
Critical Reviews in Oncogenesis. 2011-01-01
Abstracts/Posters
- CK2 Inhibitor CX4945 Shows Strong In Vivo Synergistic Anti-Leukemia Activity with Rapamycin in B-ALL Due to Enhanced Ikaros Mediated Repression of mTOR PathwaySinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- CK2 Inhibitor CX4945 Shows Strong In Vivo Anti Leukemia Effect in AML Via Augmented Ikaros-Mediated Regulation of Global Epigenetic LandscapeSinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Oncogenesis of CRLF2 Overexpression and Effect of JAK2 Inhibitor in CRLF2 Overexpressed B-Cell Acute Lymphoblastic LeukemiaSinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
College of Medicine Awarded $4 Million Grant to Advance Pediatric Oncology ResearchSeptember 25th, 2024- Increased Incidence of IKZF1 Deletions and IGH-CRLF2 Translocations in B-ALL of Hispanic/Latino Children—a Novel Health DisparityFebruary 2nd, 2021
- Genetic Variants Could Explain High Leukemia Rates in Hispanic ChildrenFebruary 2nd, 2021
- Join now to see all
Grant Support
- The Role Of Zinc Finger Genes In LeukemogenesisNational Heart, Lung, And Blood Institute2010–2011
- The Role Of Zinc Finger Genes In LeukemogenesisNational Heart, Lung, And Blood Institute2009–2010
- The Role Of Zinc Finger Genes In Cellular ProliferationNational Cancer Institute2005–2007
- The Role Of Zinc Finger Genes In HematopoiesisNational Cancer Institute2003
- The Role Of Zinc Finger Genes In HematopoiesisNational Cancer Institute1999–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
